A M Coudray

517 total citations
13 papers, 438 citations indexed

About

A M Coudray is a scholar working on Oncology, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, A M Coudray has authored 13 papers receiving a total of 438 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Molecular Biology and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in A M Coudray's work include Colorectal Cancer Treatments and Studies (3 papers), Chemical Synthesis and Analysis (2 papers) and Diabetes Treatment and Management (2 papers). A M Coudray is often cited by papers focused on Colorectal Cancer Treatments and Studies (3 papers), Chemical Synthesis and Analysis (2 papers) and Diabetes Treatment and Management (2 papers). A M Coudray collaborates with scholars based in France and Sweden. A M Coudray's co-authors include G Rosselin, D. Bataille, Viktor Mutt, Christian Gespach, M.E. Forgue-Lafitte, B. Bréant, Julien C. Marie, Kazuhiko Tatemoto, Ján Mešter and Dominique Fagot and has published in prestigious journals such as The Journal of Immunology, FEBS Letters and Experimental Cell Research.

In The Last Decade

A M Coudray

12 papers receiving 428 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A M Coudray France	10	175	141	139	116	82	13	438
Stacey Conarello United States	6	357 2.0×	192 1.4×	132 0.9×	278 2.4×	122 1.5×	10	643
Jose Gasalla-Herraiz United States	11	120 0.7×	196 1.4×	57 0.4×	67 0.6×	23 0.3×	15	438
Tokuyuki Yamashita Japan	9	410 2.3×	344 2.4×	97 0.7×	450 3.9×	62 0.8×	14	735
Robert J. Bloom United States	8	57 0.3×	143 1.0×	110 0.8×	88 0.8×	24 0.3×	12	359
Daniela Nasteska United Kingdom	13	323 1.8×	262 1.9×	66 0.5×	324 2.8×	65 0.8×	24	652
Suad Efendic Sweden	9	99 0.6×	213 1.5×	105 0.8×	120 1.0×	18 0.2×	11	364
Lynetta J. Jobe United States	6	134 0.8×	127 0.9×	41 0.3×	97 0.8×	22 0.3×	7	355
Charles Xing United States	8	185 1.1×	211 1.5×	98 0.7×	113 1.0×	19 0.2×	20	424
Nicole Bernad France	12	37 0.2×	183 1.3×	206 1.5×	55 0.5×	32 0.4×	30	394
Hidetada Ogata Japan	13	157 0.9×	131 0.9×	14 0.1×	140 1.2×	35 0.4×	22	410

Countries citing papers authored by A M Coudray

Since Specialization

Citations

This map shows the geographic impact of A M Coudray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A M Coudray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A M Coudray more than expected).

Fields of papers citing papers by A M Coudray

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A M Coudray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A M Coudray. The network helps show where A M Coudray may publish in the future.

Co-authorship network of co-authors of A M Coudray

This figure shows the co-authorship network connecting the top 25 collaborators of A M Coudray. A scholar is included among the top collaborators of A M Coudray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A M Coudray. A M Coudray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Coudray, A M, Christophe Louvet, Michel Kornprobst, et al.. (2005). Increased anticancer activity of the thymidylate synthase inhibitor BGC9331 combined with the topoisomerase I inhibitor SN-38 in human colorectal and breast cancer cells: Induction of apoptosis and ROCK cleavage through caspase-3-dependent and -independent mechanisms. International Journal of Oncology. 27(2). 553–61. 9 indexed citations

Raymond, Eric, Sandrine Faivre, A M Coudray, Christophe Louvet, & Christian Gespach. (2001). [Preclinical studies of oxaliplatin in combination chemotherapy].. PubMed. 88 Spec No. S26–34. 10 indexed citations

Louvet, Christophe, A M Coudray, Christophe Tournigand, et al.. (2000). Synergistic antitumoral activity of combined UFT, folinic acid and oxaliplatin against human colorectal HT29 cell xenografts in athymic nude mice. Anti-Cancer Drugs. 11(7). 579–582. 18 indexed citations

Marie, Jean‐Claude, A. Wakkach, A M Coudray, et al.. (1999). Functional Expression of Receptors for Calcitonin Gene-Related Peptide, Calcitonin, and Vasoactive Intestinal Peptide in the Human Thymus and Thymomas from Myasthenia Gravis Patients. The Journal of Immunology. 162(4). 2103–2112. 26 indexed citations

Forgue-Lafitte, M.E., A M Coudray, Jean Aubert, Christian Gespach, & Jennifer J. Bara. (1996). Devazepide (L-364718) inhibits growth and increases expression of tumor markers in HT29-S-B6 cells.. PubMed. 319(12). 1133–8. 1 indexed citations

Forgue‐Lafitte, Marie‐Elisabeth, A M Coudray, Ján Mešter, Christian Gespach, & G Rosselin. (1996). <b>ANTIMITOGENIC EFFECTS OF THE GASTRIN-CCK RECEPTORS’ ANTAGONISTS L-364718 AND L-365260 IN HUMAN COLON CANCER CELL CLONE HT29-S-B6: CELL CYCLE ANALYSIS AND MODULATION BY </b><b>SERUM </b>. Biomedical Research. 17(6). 457–464. 3 indexed citations

Forgue-Lafitte, M.E., A M Coudray, Dominique Fagot, & Ján Mešter. (1992). Effects of ketoconazole on the proliferation and cell cycle of human cancer cell lines.. PubMed. 52(24). 6827–31. 21 indexed citations

Bréant, Bernadette, et al.. (1990). Differentiation of newborn rat preadipocytes in culture: Effects of insulin and dexamethasone. Experimental Cell Research. 191(1). 133–140. 14 indexed citations

Forgue-Lafitte, M.E., et al.. (1989). Proliferation of the human colon carcinoma cell line HT29: autocrine growth and deregulated expression of the c-myc oncogene.. PubMed. 49(23). 6566–71. 58 indexed citations

10.

Bataille, D., et al.. (1983). Isolation and chemical characterization of glucagon-37 (bioactive enteroglucagon/oxyntomodulin) from porcine jejuno-ileum. Regulatory Peptides. 5. 95–95.

11.

Bataille, D., et al.. (1982). Isolation of glucagon‐37 (bioactive enteroglucagon/oxyntomodulin) from porcine jejuno‐ileum. FEBS Letters. 146(1). 73–78. 140 indexed citations

12.

Bataille, D., Christian Gespach, Kazuhiko Tatemoto, et al.. (1981). Bioactive enteroglucagon (oxyntomodulin): Present knowledge on its chemical structure and its biological activities. Peptides. 2. 41–44. 68 indexed citations

13.

Bataille, D., Christian Gespach, A M Coudray, & G Rosselin. (1981). ‘Enteroglucagon’: A specific effect on gastric glands isolated from the rat fundus. Evidence for an ‘oxyntomodulin’ action. Bioscience Reports. 1(2). 151–155. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact